Acadia Pharmaceuticals | ACAD - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Acadia Pharmaceuticals

Acadia Pharmaceuticals reported $1.67M in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US USD 1.67M 746K
ALKERMES ALKS:US USD 58.18M 4.21M
Alnylam Pharmaceuticals ALNY:US USD 54.87M 3.6M
Biogen BIIB:US USD 662.8M 91.9M
BioMarin Pharmaceutical BMRN:US USD 126.55M 741K
Bristol-Myers Squibb BMY:US USD 2.56B 45M
Cara Therapeutics CARA:US USD 2.59M 460K
Corcept Therapeutics CORT:US USD 1.39M 94K
Eisai 4523:JP JPY 38.57B 8.17B
Eli Lilly LLY:US USD 1.63B 78.6M
Incyte Corp INCY:US USD 51.42M 2.34M
Intercept Pharmaceuticals ICPT:US USD 222K 194K
Intra Cellular Therapies ITCI:US USD 6.75M 37K
J&J JNJ:US USD 8.4B 684M
Marinus Pharmaceuticals MRNS:US USD 206K 86K
Moderna Inc MRNA:US USD 792M 1.13B
Neurocrine Biosciences NBIX:US USD 8.5M 800K
Pfizer PFE:US USD 5.03B 4.8B
PTC Therapeutics PTCT:US USD 14.14M 3.25M
Sarepta Therapeutics SRPT:US USD 35.02M 4.22M
Seattle Genetics SGEN:US USD 111.78M 3.57M
Ultragenyx Pharmaceutical RARE:US USD 12.26M 6.94M
Vanda Pharmaceuticals VNDA:US USD 4.77M 1.46M
Vertex Pharmaceuticals VRTX:US USD 266.9M 16.4M